XENIA PHARMA ApS: Financial statements 2020
CVR: 35529454
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
XENIA PHARMA ApS (CVR 35529454) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -2,236 and a net result of DKK -2,236 compared with DKK -3,449 the year before. Equity in the 2020 report amounted to DKK -1,447.
- Gross Profit
- DKK -2,236
- Profit/Loss
- DKK -2,236
- Equity
- DKK -1,447
- Total Assets
- DKK 42,769
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -2K | -2K | -1K | - |
| 2019 | - | -3K | -3K | 789 | - |
| 2018 | - | -25K | -25K | 4K | - |
| 2017 | - | -3K | -3K | 29K | - |
| 2016 | - | -47K | -47K | 33K | 0 |
Official annual report
How creditworthy is XENIA PHARMA ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
XENIA PHARMA ApS has published its annual report for 2019. Gross profit came to DKK -3,399, and the net result was DKK -3,449.
About XENIA PHARMA ApS
XENIA PHARMA ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2013. The company is registered under the industry Dyrlægeaktiviteter. The management consists of Dorte Xenia Gram. The company is owned by Dorte Xenia Gram. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -28,827 and a net result of DKK -28,855 compared with DKK -18,952 the year before. Equity in the 2025 report amounted to DKK -46,501.